Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: A case report

Journal of Clinical Psychopharmacology

Volumn 33, Issue 2, 2013, Pages 270-272

  Zigman, Daniel ^a   Blier, Pierre ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; DULOXETINE; ESCITALOPRAM; KETAMINE; LITHIUM; MOCLOBEMIDE; PAROXETINE; QUETIAPINE; RISPERIDONE; VENLAFAXINE;

ADULT; ANXIETY; CASE REPORT; COGNITIVE THERAPY; DISABILITY; DISEASE SEVERITY; DYSPHORIA; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW UP; HUMAN; JOB PERFORMANCE; LETTER; LOW DRUG DOSE; MAJOR DEPRESSION; PRIORITY JOURNAL; SUICIDAL IDEATION; TREATMENT RESPONSE;

ADULT; ANESTHETICS, DISSOCIATIVE; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; SUICIDAL IDEATION;

EID: 84874936818     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182856865     Document Type: Letter

References (9)

1. Zarate CA Jr, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856-864. (Pubitemid 44188478)
2. Diazgranados N, Ibrahim L, Brutsche NE, et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry. 2010;67(8): 793-802.
3. Zarate CA Jr, Brutsche NE, Ibrahim L, et al. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry. 2012;71(11):939-946.
4. DiazGranados N, Ibrahim LA, Brutsche NE, et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry. 2010;71(12): 1605-1611.
5. Price RB, Nock MK, Charney DS, et al. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry. 2009;66(5): 522-526.
6. Larkin GL, Beautrais AL. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol. 2011;14(8): 1127-1131.
7. Messer M, Haller IV, Larson P, et al. The use of a series of ketamine infusions in two patients with treatment-resistant depression. J Neuropsychiatry Clin Neurosci. 2010;22(4):442-444.
8. Perry EB Jr, Cramer JA, Cho HS, et al. Psychiatric safety of ketamine in psychopharmacology research. Psychopharmacology (Berl). 2007;192(2): 253-260. (Pubitemid 46669207)
9. Patil S, Anitescu M. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis. Pain Med. 2012;13(2): 263-269.